Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-01
1998-06-09
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514866, 530303, 424451, 424464, A61K 3828
Patent
active
057633967
ABSTRACT:
Disclosed herein are methods for treating or preventing a disease in mammals having the characteristics of Type 1 diabetes comprising administering insulin or disease suppressive fragments of insulin or analogs thereof in oral or aerosol dosage forms to said mammals. Also disclosed herein are pharmaceutical formulation or dosage forms for use in the methods.
REFERENCES:
patent: 4362719 (1982-12-01), Cavazza et al.
patent: 4579730 (1986-04-01), Kidron et al.
patent: 4608364 (1986-08-01), Grau
patent: 4963526 (1990-10-01), Ecanow
Eisenbarth, G.S., New Eng. J. Med. 314:1360 (1986).
Braley-Mullen, H. et al., Cell, Immunol, 51:408-413 (1980).
Keller, R.J., J. Autoimmunity 3:321-327 (1990).
Marx, Science, 252:27-28 (1991).
Ziegler, A.G., et al., Diabetes Care 13:762-775 (1990).
Eisenberth George
Hafler David Allen
Weiner Howard L.
Zhang Zhengi
Autoimmune Inc.
Celsa Bennett
Tsang Cecilia J.
LandOfFree
Method of treating or preventing type 1 diabetes by oral adminis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating or preventing type 1 diabetes by oral adminis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating or preventing type 1 diabetes by oral adminis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199110